{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:06:27Z","timestamp":1791227187575,"version":"4.1.0"},"reference-count":102,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Coordination for the Improvement of Higher Education Personnel-Brazil","award":["#88887.334572\/2019-00"],"award-info":[{"award-number":["#88887.334572\/2019-00"]}]},{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"publisher","award":["19\/24591-4"],"award-info":[{"award-number":["19\/24591-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Consistent with postmortem findings in patients, most animal models for schizophrenia (SCZ) present abnormal levels of parvalbumin (PV), a marker of fast-spiking GABAergic interneurons, in the prefrontal cortex (PFC) and hippocampus (HIP). However, there are discrepancies in the literature. PV reductions lead to a functional loss of PV interneurons, which is proposed to underly SCZ symptoms. Given its complex etiology, different categories of animal models have been developed to study SCZ, which may distinctly impact PV levels in rodent brain areas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Design<\/jats:title>\n                    <jats:p>We performed a quantitative meta-analysis on PV-positive cell number\/density and expression levels in the PFC and HIP of animal models for SCZ based on pharmacological, neurodevelopmental, and genetic manipulations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our results confirmed that PV levels are significantly reduced in the PFC and HIP regardless of the animal model. By categorizing into subgroups, we found that all pharmacological models based on NMDA receptor antagonism decreased PV-positive cell number\/density or PV expression levels in both brain areas examined. In neurodevelopmental models, abnormal PV levels were confirmed in both brain areas in maternal immune activation models and HIP of the methylazoxymethanol acetate model. In genetic models, negative effects were found in neuregulin 1 and ERBB4 mutant mice in both brain regions and the PFC of dysbindin mutant mice. Regarding sex differences, male rodents exhibited PV reductions in both brain regions only in pharmacological models, while few studies have been conducted in females.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overall, our findings support deficits in prefrontal and hippocampal PV interneurons in animal models for SCZ.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/schbul\/sbad123","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T16:13:45Z","timestamp":1690992825000},"page":"210-223","source":"Crossref","is-referenced-by-count":38,"title":["Prefrontal and Hippocampal Parvalbumin Interneurons in Animal Models for Schizophrenia: A Systematic Review and Meta-analysis"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5129-5695","authenticated-orcid":false,"given":"Thamyris","family":"Santos-Silva","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo , Ribeir\u00e3o Preto ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora","family":"dos Santos Fabris","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Behavioral Sciences, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo , Ribeir\u00e3o Preto ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cilene Lino","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"Department of Physiological Sciences, Center of Biological Sciences, University of Santa Catarina , Florian\u00f3polis,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco S","family":"Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo , Ribeir\u00e3o Preto ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1033-1850","authenticated-orcid":false,"given":"Felipe V","family":"Gomes","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo , Ribeir\u00e3o Preto ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"issue":"12","key":"2026041420040372400_CIT0001","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.biopsych.2015.03.010","article-title":"Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia","volume":"77","author":"Gonzalez-Burgos","year":"2015","journal-title":"Biol Psychiatry."},{"key":"2026041420040372400_CIT0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2021.679960","article-title":"The role of parvalbumin interneurons in neurotransmitter balance and neurological disease","volume":"12","author":"Nahar","year":"2021","journal-title":"Front Psychiatry."},{"issue":"3","key":"2026041420040372400_CIT0003","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0920-9964(96)00122-3","article-title":"Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics","volume":"24","author":"Beasley","year":"1997","journal-title":"Schizophr Res."},{"issue":"7","key":"2026041420040372400_CIT0004","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0006-3223(02)01360-4","article-title":"Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins","volume":"52","author":"Beasley","year":"2002","journal-title":"Biol Psychiatry."},{"issue":"12","key":"2026041420040372400_CIT0005","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00702-019-02080-2","article-title":"Prefrontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies","volume":"126","author":"Kaar","year":"2019","journal-title":"J Neural Transm."},{"issue":"1\u20132","key":"2026041420040372400_CIT0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00188-8","article-title":"A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia","volume":"55","author":"Zhang","year":"2002","journal-title":"Schizophr Res."},{"issue":"1\u20133","key":"2026041420040372400_CIT0007","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.schres.2011.06.007","article-title":"Hippocampal interneurons are abnormal in schizophrenia","volume":"131","author":"Konradi","year":"2011","journal-title":"Schizophr Res."},{"issue":"7","key":"2026041420040372400_CIT0008","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00702-023-02650-5","article-title":"Excitatory and inhibitory imbalances in the trisynaptic pathway in the hippocampus in schizophrenia: a postmortem ultrastructural study","volume":"130","author":"Farmer","year":"2013","journal-title":"J Neural Transm."},{"issue":"7","key":"2026041420040372400_CIT0009","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/mp.2017.47","article-title":"Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia","volume":"22","author":"Steullet","year":"2017","journal-title":"Mol Psychiatry."},{"issue":"1\u20132","key":"2026041420040372400_CIT0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cell.2015.11.038","article-title":"Prefrontal parvalbumin neurons in control of attention","volume":"164","author":"Kim","year":"2016","journal-title":"Cell."},{"issue":"7247","key":"2026041420040372400_CIT0011","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nature07991","article-title":"Parvalbumin neurons and gamma rhythms enhance cortical circuit performance","volume":"459","author":"Sohal","year":"2009","journal-title":"Nature."},{"issue":"9","key":"2026041420040372400_CIT0012","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1073\/pnas.0813176106","article-title":"Hippocampal theta rhythm and its coupling with gamma oscillations require fast inhibition onto parvalbumin-positive interneurons","volume":"106","author":"Wulff","year":"2009","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"2026041420040372400_CIT0013","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.neuron.2015.05.027","article-title":"Parvalbumin interneurons of hippocampus tune population activity at theta frequency","volume":"86","author":"Amilhon","year":"2015","journal-title":"Neuron."},{"issue":"8","key":"2026041420040372400_CIT0014","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrn.2016.57","article-title":"Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression","volume":"17","author":"Grace","year":"2016","journal-title":"Nat Rev Neurosci."},{"issue":"1","key":"2026041420040372400_CIT0015","first-page":"1","article-title":"Hippocampal circuit dysfunction in psychosis","volume":"12","author":"Knight","year":"2022","journal-title":"Transl Psychiatry."},{"issue":"1","key":"2026041420040372400_CIT0016","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/schbul\/sbx199","article-title":"The circuitry of dopamine system regulation and its disruption in schizophrenia: insights into treatment and prevention","volume":"45","author":"Grace","year":"2019","journal-title":"Schizophr Bull."},{"key":"2026041420040372400_CIT0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2020.00613","article-title":"Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia","volume":"11","author":"Sonnenschein","year":"2020","journal-title":"Front Psychiatry."},{"issue":"2","key":"2026041420040372400_CIT0018","first-page":"407","article-title":"Aberrant hippocampal regulation of dopamine neuron responsivity in an animal model of schizophrenia","volume":"33","author":"Lodge","year":"2007","journal-title":"Schizophr Bull."},{"key":"2026041420040372400_CIT0019","first-page":"32","article-title":"Advantages and limitations of animal schizophrenia models and limitations of animal schizophrenia models","volume":"1","author":"Bialon","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"1","key":"2026041420040372400_CIT0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41398-021-01273-2","article-title":"How do established developmental risk-factors for schizophrenia change the way the brain develops","volume":"11","author":"Eyles","year":"2021","journal-title":"Transl Psychiatry."},{"issue":"3","key":"2026041420040372400_CIT0021","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/YCO.0000000000000854","article-title":"Update on current animal models for schizophrenia: are they still useful","volume":"36","author":"Uliana","year":"2023","journal-title":"Curr Opin Psychiatry."},{"issue":"7","key":"2026041420040372400_CIT0022","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"2026041420040372400_CIT0023","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2006","journal-title":"Syst Rev"},{"key":"2026041420040372400_CIT0024","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol."},{"issue":"2","key":"2026041420040372400_CIT0025","doi-asserted-by":"crossref","first-page":"597","DOI":"10.22237\/jmasm\/1257035100","article-title":"New effect size rules of thumb","volume":"8","author":"Sawilowsky","year":"2009","journal-title":"J Mod Appl Stat Methods"},{"issue":"4","key":"2026041420040372400_CIT0026","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1469-185X.2007.00027.x","article-title":"Effect size, confidence interval and statistical significance: a practical guide for biologists","volume":"82","author":"Nakagawa","year":"2007","journal-title":"Biol Rev Camb Philos Soc."},{"issue":"7414","key":"2026041420040372400_CIT0027","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2026041420040372400_CIT0028","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2013.06.040","article-title":"Chronic ketamine produces altered distribution of parvalbumin-positive cells in the hippocampus of adult rats","volume":"550","author":"Sabbagh","year":"2013","journal-title":"Neurosci Lett."},{"issue":"1","key":"2026041420040372400_CIT0029","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41398-019-0436-3","article-title":"Downregulation of Npas4 in parvalbumin interneurons and cognitive deficits after neonatal NMDA receptor blockade: relevance for schizophrenia","volume":"9","author":"Shepard","year":"2019","journal-title":"Transl Psychiatry."},{"issue":"5","key":"2026041420040372400_CIT0030","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000454677","article-title":"Early development of parvalbumin-, somatostatin-, and cholecystokinin-expressing neurons in rat brain following prenatal immune activation and maternal iron deficiency","volume":"38","author":"Boksa","year":"2017","journal-title":"Dev Neurosci."},{"issue":"1","key":"2026041420040372400_CIT0031","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11011-018-0359-3","article-title":"Adolescent social isolation affects parvalbumin expression in the medial prefrontal cortex in the MAM-E17 model of schizophrenia","volume":"34","author":"Ma\u0107kowiak","year":"2019","journal-title":"Metab Brain Dis."},{"key":"2026041420040372400_CIT0032","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1756-6606-6-20","article-title":"Abnormal interneuron development in disrupted-in-schizophrenia-1 L100P mutant mice","volume":"6","author":"Lee","year":"2013","journal-title":"Mol Brain"},{"key":"2026041420040372400_CIT0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnbeh.2022.935320","article-title":"Using animal models for the studies of schizophrenia and depression: the value of translational models for treatment and prevention","volume":"16","author":"Uliana","year":"2022","journal-title":"Front Behav Neurosci."},{"issue":"1","key":"2026041420040372400_CIT0034","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tins.2011.10.004","article-title":"Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia","volume":"35","author":"Lewis","year":"2012","journal-title":"Trends Neurosci."},{"key":"2026041420040372400_CIT0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-023-01991-7","article-title":"Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis","author":"Merritt","year":"2023","journal-title":"Mol Psychiatry."},{"issue":"13","key":"2026041420040372400_CIT0036","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1038\/s41386-017-0004-6","article-title":"Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis","volume":"43","author":"Modinos","year":"2018","journal-title":"Neuropsychopharmacology."},{"key":"2026041420040372400_CIT0037","doi-asserted-by":"crossref","first-page":"929469","DOI":"10.3389\/fnins.2022.929469","article-title":"Origin, development, and synaptogenesis of cortical interneurons","volume":"16","author":"Llorca","year":"2022","journal-title":"Front Neurosci."},{"issue":"4","key":"2026041420040372400_CIT0038","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1152\/physrev.00007.2017","article-title":"Hippocampal gabaergic inhibitory interneurons","volume":"97","author":"Pelkey","year":"2017","journal-title":"Physiol Rev."},{"issue":"7","key":"2026041420040372400_CIT0039","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1176\/appi.ajp.20220676","article-title":"The nature of prefrontal cortical GABA neuron alterations in schizophrenia: markedly lower somatostatin and parvalbumin gene expression without missing neurons","volume":"180","author":"Dienel","year":"2023","journal-title":"Am J Psychiatry."},{"issue":"12","key":"2026041420040372400_CIT0040","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1017\/S0033291716001446","article-title":"Cortical GABA markers identify a molecular subtype of psychotic and bipolar disorders","volume":"46","author":"Volk","year":"2016","journal-title":"Psychol Med."},{"issue":"7","key":"2026041420040372400_CIT0041","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/mp.2017.216","article-title":"Transcriptome alterations of prefrontal cortical parvalbumin neurons in schizophrenia","volume":"23","author":"Enwright","year":"2018","journal-title":"Mol Psychiatry."},{"issue":"11","key":"2026041420040372400_CIT0042","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.biopsych.2018.07.010","article-title":"Transcriptomic evidence for alterations in astrocytes and parvalbumin interneurons in subjects with bipolar disorder and schizophrenia","volume":"84","author":"Toker","year":"2018","journal-title":"Biol Psychiatry."},{"issue":"5","key":"2026041420040372400_CIT0043","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/schbul\/sbs010","article-title":"NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia","volume":"38","author":"Gonzalez-Burgos","year":"2012","journal-title":"Schizophr Bull."},{"issue":"2","key":"2026041420040372400_CIT0044","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881114563634","article-title":"Glutamate and dopamine in schizophrenia: an update for the 21st century","volume":"29","author":"Howes","year":"2015","journal-title":"J Psychopharmacol."},{"issue":"3","key":"2026041420040372400_CIT0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.neuron.2010.09.017","article-title":"NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory","volume":"68","author":"Korotkova","year":"2010","journal-title":"Neuron."},{"key":"2026041420040372400_CIT0046","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1038\/npp.2009.20","article-title":"Cell type-specific development of NMDA receptors in the interneurons of rat prefrontal cortex","volume":"34","author":"Wang","year":"2009","journal-title":"Neuropsychopharmacology."},{"key":"2026041420040372400_CIT0047","first-page":"119","article-title":"Study schizophrenomimetic drug sernyl","volume":"113","author":"Luby","year":"1959","journal-title":"AMA Arch Neurol Psychiatry"},{"issue":"3","key":"2026041420040372400_CIT0048","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krysta","year":"1994","journal-title":"Arch Gen Psychiatry."},{"issue":"3","key":"2026041420040372400_CIT0049","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00213-007-0729-8","article-title":"Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine","volume":"192","author":"Abekawa","year":"2007","journal-title":"Psychopharmacology."},{"issue":"5","key":"2026041420040372400_CIT0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyu041","article-title":"Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice","volume":"18","author":"Gomes","year":"2015","journal-title":"Intl J Neuropsychopharmacol"},{"issue":"2","key":"2026041420040372400_CIT0051","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbr.2008.07.020","article-title":"Disturbances in social interaction occur along with pathophysiological deficits following sub-chronic phencyclidine administration in the rat","volume":"194","author":"Jenkins","year":"2008","journal-title":"Behav Brain Res"},{"issue":"6","key":"2026041420040372400_CIT0052","doi-asserted-by":"crossref","first-page":"e0157021","DOI":"10.1371\/journal.pone.0157021","article-title":"Pharmacological investigations of the dissociative \u201cLegal Highs\u201d diphenidine, methoxphenidine and analogues","volume":"11","author":"Wallach","year":"2016","journal-title":"PLoS One."},{"issue":"6","key":"2026041420040372400_CIT0053","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia","volume":"33","author":"Olney","year":"1999","journal-title":"J Psychiatr Res."},{"issue":"6","key":"2026041420040372400_CIT0054","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/npp.2011.324","article-title":"Prenatal NMDA receptor antagonism impaired proliferation of neuronal progenitor, leading to fewer glutamatergic neurons in the prefrontal cortex","volume":"37","author":"Toriumi","year":"2012","journal-title":"Neuropsychopharmacology."},{"issue":"1","key":"2026041420040372400_CIT0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.mp.4000912","article-title":"Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity","volume":"7","author":"Farber","year":"2002","journal-title":"Mol Psychiatry."},{"issue":"7","key":"2026041420040372400_CIT0056","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.tins.2016.04.010","article-title":"GABAergic function as a limiting factor for prefrontal maturation during adolescence","volume":"39","author":"Caballero","year":"2016","journal-title":"Trends Neurosci."},{"issue":"4","key":"2026041420040372400_CIT0057","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jchemneu.2003.09.005","article-title":"Postnatal development of calcium-binding proteins immunoreactivity (parvalbumin, calbindin, calretinin) in the human entorhinal cortex","volume":"26","author":"Grateron","year":"2003","journal-title":"J Chem Neuroanat."},{"issue":"12","key":"2026041420040372400_CIT0058","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/hipo.22172","article-title":"Region-specific upregulation of parvalbumin-, but not calretinin-positive cells in the ventral hippocampus during adolescence","volume":"23","author":"Caballero","year":"2013","journal-title":"Hippocampus."},{"issue":"1","key":"2026041420040372400_CIT0059","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00429-013-0508-8","article-title":"Differential regulation of parvalbumin and calretinin interneurons in the prefrontal cortex during adolescence","volume":"219","author":"Caballero","year":"2014","journal-title":"Brain Struct Funct."},{"key":"2026041420040372400_CIT0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neubiorev.2018.07.001","article-title":"Prenatal exposure to environmental insults and enhanced risk of developing Schizophrenia and Autism Spectrum Disorder: focus on biological pathways and epigenetic mechanisms","volume":"117","author":"Cattane","year":"2020","journal-title":"Neurosci Biobehav Rev."},{"key":"2026041420040372400_CIT0061","doi-asserted-by":"crossref","first-page":"101967","DOI":"10.1016\/j.pneurobio.2020.101967","article-title":"The prefrontal cortex as a target for atypical antipsychotics in schizophrenia, lessons of neurodevelopmental animal models","volume":"199","author":"Tendilla-Beltr\u00e1n","year":"2021","journal-title":"Prog Neurobiol."},{"issue":"3","key":"2026041420040372400_CIT0062","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.biopsych.2006.01.003","article-title":"A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia","volume":"60","author":"Moore","year":"2006","journal-title":"Biol Psychiatry."},{"key":"2026041420040372400_CIT0063","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neubiorev.2016.05.030","article-title":"Adolescence as a period of vulnerability and intervention in schizophrenia: insights from the MAM model","volume":"70","author":"Gomes","year":"2016","journal-title":"Neurosci Biobehav Rev."},{"issue":"3","key":"2026041420040372400_CIT0064","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1017\/S146114571400056X","article-title":"Corresponding decrease in neuronal markers signals progressive parvalbumin neuron loss in MAM schizophrenia model","volume":"17","author":"Gill","year":"2014","journal-title":"Int J Neuropsychopharmacol."},{"issue":"4","key":"2026041420040372400_CIT0065","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/npp.2011.298","article-title":"Selective remediation of reversal learning deficits in the neurodevelopmental MAM model of schizophrenia by a novel mGlu5 positive allosteric modulator","volume":"37","author":"Gastambide","year":"2012","journal-title":"Neuropsychopharmacology."},{"issue":"1","key":"2026041420040372400_CIT0066","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1460-9568.2005.04536.x","article-title":"Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia","volume":"23","author":"Penschuck","year":"2006","journal-title":"Eur J Neurosci."},{"key":"2026041420040372400_CIT0067","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neubiorev.2020.04.012","article-title":"Maternal immune activation by Poly I:C as a preclinical model for neurodevelopmental disorders: a focus on autism and schizophrenia","volume":"113","author":"Haddad","year":"2020","journal-title":"Neurosci Biobehav Rev."},{"key":"2026041420040372400_CIT0068","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pnpbp.2014.10.004","article-title":"Prenatal LPS-exposure - a neurodevelopmental rat model of schizophrenia - differentially affects cognitive functions, myelination and parvalbumin expression in male and female offspring","volume":"57","author":"Wischhof","year":"2015","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"issue":"1","key":"2026041420040372400_CIT0069","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/npp.1993.44","article-title":"Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia","volume":"9","author":"Lipska","year":"1993","journal-title":"Neuropsychopharmacology."},{"issue":"7","key":"2026041420040372400_CIT0070","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.biopsych.2006.10.012","article-title":"Post-pubertal disruption of medial prefrontal cortical dopamine\u2013glutamate interactions in a developmental animal model of schizophrenia","volume":"62","author":"Tseng","year":"2007","journal-title":"Biol Psychiatry."},{"issue":"9","key":"2026041420040372400_CIT0071","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/cercor\/12.9.975","article-title":"Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats","volume":"12","author":"O\u2019Donnell","year":"2002","journal-title":"Cereb Cortex."},{"issue":"48","key":"2026041420040372400_CIT0072","doi-asserted-by":"crossref","first-page":"12691","DOI":"10.1523\/JNEUROSCI.4166-08.2008","article-title":"Neurobiology of disease a neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons","volume":"28","author":"Tseng","year":"2008","journal-title":"J Neurosci."},{"issue":"4","key":"2026041420040372400_CIT0073","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/dev.21390","article-title":"Effects of early adolescent environmental enrichment on cognitive dysfunction, prefrontal cortex development, and inflammatory cytokines after early life stress","volume":"58","author":"do Prado","year":"2016","journal-title":"Dev Psychobiol."},{"key":"2026041420040372400_CIT0074","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neulet.2014.02.023","article-title":"Early life stress disrupts social behavior and prefrontal cortex parvalbumin interneurons at an earlier time-point in females than in males","volume":"566","author":"Holland","year":"2014","journal-title":"Neurosci Lett."},{"key":"2026041420040372400_CIT0075","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuroscience.2017.07.016","article-title":"Region-specific impairments in parvalbumin interneurons in social isolation-reared mice","volume":"359","author":"Ueno","year":"2017","journal-title":"Neuroscience."},{"issue":"7","key":"2026041420040372400_CIT0076","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00702-007-0627-6","article-title":"Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats","volume":"114","author":"Harte","year":"2007","journal-title":"J Neural Transm."},{"issue":"12","key":"2026041420040372400_CIT0077","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1038\/npp.2015.134","article-title":"Functional uncoupling NMDAR NR2A subunit from PSD-95 in the prefrontal cortex: effects on behavioral dysfunction and parvalbumin loss after early-life stress","volume":"40","author":"Ganguly","year":"2015","journal-title":"Neuropsychopharmacology."},{"key":"2026041420040372400_CIT0078","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neuroscience.2018.08.030","article-title":"Adolescent stress disrupts the maturation of anxiety-related behaviors and alters the developmental trajectory of the prefrontal cortex in a sex- and age-specific manner","volume":"390","author":"Page","year":"2018","journal-title":"Neuroscience."},{"issue":"1","key":"2026041420040372400_CIT0079","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2011.03.022","article-title":"Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls","volume":"129","author":"Pruessner","year":"2011","journal-title":"Schizophr Res."},{"key":"2026041420040372400_CIT0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.schres.2019.01.030","article-title":"Stress during critical periods of development and risk for schizophrenia","volume":"213","author":"Gomes","year":"2019","journal-title":"Schizophr Res."},{"issue":"22","key":"2026041420040372400_CIT0081","doi-asserted-by":"crossref","first-page":"9130","DOI":"10.1073\/pnas.1300454110","article-title":"Perineuronal nets protect fast-spiking interneurons against oxidative stress","volume":"110","author":"Cabungcal","year":"2013","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7906","key":"2026041420040372400_CIT0082","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","article-title":"Mapping genomic loci implicates genes and synaptic biology in schizophrenia","volume":"604","author":"Trubetskoy","year":"2022","journal-title":"Nature."},{"issue":"1","key":"2026041420040372400_CIT0083","first-page":"1","article-title":"Epidemiology and risk factors of schizophrenia","volume":"37","author":"Janoutov\u00e1","year":"2016","journal-title":"Neuro Endocrinol Lett."},{"issue":"43","key":"2026041420040372400_CIT0084","doi-asserted-by":"crossref","first-page":"10893","DOI":"10.1523\/JNEUROSCI.3299-08.2008","article-title":"Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1","volume":"28","author":"Shen","year":"2008","journal-title":"J Neurosci."},{"issue":"36","key":"2026041420040372400_CIT0085","doi-asserted-by":"crossref","first-page":"14501","DOI":"10.1073\/pnas.0704774104","article-title":"Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans","volume":"104","author":"Hikida","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"49","key":"2026041420040372400_CIT0086","doi-asserted-by":"crossref","first-page":"84798","DOI":"10.18632\/oncotarget.21381","article-title":"A prenatal interruption of DISC1 function in the brain exhibits a lasting impact on adult behaviors, brain metabolism, and interneuron development","volume":"8","author":"Deng","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"2026041420040372400_CIT0087","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1007\/s00213-019-05285-1","article-title":"Loss of dysbindin-1 affects GABAergic transmission in the PFC","volume":"236","author":"Trantham-Davidson","year":"2019","journal-title":"Psychopharmacology."},{"issue":"43","key":"2026041420040372400_CIT0088","doi-asserted-by":"crossref","first-page":"E962","DOI":"10.1073\/pnas.1109625108","article-title":"Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia","volume":"108","author":"Carlson","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"50","key":"2026041420040372400_CIT0089","doi-asserted-by":"crossref","first-page":"19724","DOI":"10.1523\/JNEUROSCI.1584-13.2013","article-title":"Development of GABA circuitry of fast-spiking basket interneurons in the medial prefrontal cortex of erbb4-mutant mice","volume":"33","author":"Yang","year":"2013","journal-title":"J Neurosci."},{"issue":"6","key":"2026041420040372400_CIT0090","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.neuron.2013.07.010","article-title":"Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes","volume":"79","author":"delPino","year":"2013","journal-title":"Neuron."},{"issue":"7","key":"2026041420040372400_CIT0091","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1038\/tp.2012.69","article-title":"GABA B-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction","volume":"2","author":"Gandal","year":"2012","journal-title":"Transl Psychiatry."},{"issue":"3","key":"2026041420040372400_CIT0092","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1073\/pnas.0910302107","article-title":"Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons","volume":"107","author":"Wen","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2026041420040372400_CIT0093","first-page":"12","article-title":"Erbb4 deletion from inhibitory interneurons causes psychosis-relevant neuroimaging phenotypes","volume":"1","author":"Kiemes","year":"2022","journal-title":"Schizophr Bull."},{"issue":"12","key":"2026041420040372400_CIT0094","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1007\/s12035-020-02067-1","article-title":"Layers II\/III of prefrontal cortex in Df(h22q11)\/+ mouse model of the 22q11.2 deletion display loss of parvalbumin interneurons and modulation of neuronal morphology and excitability","volume":"57","author":"Al-Absi","year":"2020","journal-title":"Mol Neurobiol."},{"issue":"2","key":"2026041420040372400_CIT0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41386-020-0778-9","article-title":"Parvalbumin interneuron vulnerability and brain disorders","volume":"46","author":"Ruden","year":"2021","journal-title":"Neuropsychopharmacology."},{"issue":"7673","key":"2026041420040372400_CIT0096","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature23909","article-title":"Reversing behavioural abnormalities in mice exposed to maternal inflammation","volume":"549","author":"Shin Yim","year":"2017","journal-title":"Nature."},{"issue":"7","key":"2026041420040372400_CIT0097","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/mp.2015.222","article-title":"Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons","volume":"21","author":"Canetta","year":"2016","journal-title":"Mol Psychiatry."},{"issue":"9","key":"2026041420040372400_CIT0098","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.3390\/ijms22094467","article-title":"Beyond dopamine receptor antagonism: new targets for schizophrenia treatment and prevention","volume":"22","author":"Gomes","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"1\u20133","key":"2026041420040372400_CIT0099","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.schres.2007.05.005","article-title":"Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism","volume":"97","author":"Braun","year":"2007","journal-title":"Schizophr Res."},{"issue":"3","key":"2026041420040372400_CIT0100","doi-asserted-by":"crossref","first-page":"e1000344","DOI":"10.1371\/journal.pbio.1000344","article-title":"Publication bias in reports of animal stroke studies leads to major overstatement of efficacy","volume":"8","author":"Sena","year":"2010","journal-title":"PLoS Biol."},{"issue":"3","key":"2026041420040372400_CIT0101","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/STROKEAHA.107.498725","article-title":"Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach","volume":"39","author":"Crossley","year":"2008","journal-title":"Stroke."},{"issue":"7","key":"2026041420040372400_CIT0102","doi-asserted-by":"crossref","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/50\/1\/210\/54915447\/sbad123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/50\/1\/210\/54915447\/sbad123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:06:13Z","timestamp":1776211573000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/50\/1\/210\/7242990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,8,16]]},"published-print":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbad123","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2023,8,16]]}}}